Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06387173 · ClinicalTrials.gov registry record
Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer
A clinical trial of Early Stage Breast Carcinoma, sponsored by Jonsson Comprehensive Cancer Center.
- Active
- Registry status
- 2
- Enrollment target
- 1
- Study location
NCT06387173 is a study of Early Stage Breast Carcinoma that is active but no longer recruiting, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 2 participants, below the 454-participant average among 4 other Early Stage Breast Carcinoma trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06387173, a study of Early Stage Breast Carcinoma, is active but no longer recruiting, sponsored by Jonsson Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the side effects and outcomes of patients who undergo cryoablation for early stage breast cancer.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
California
- UCLA / Jonsson Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2024-01-04 |
| Est. Completion | 2099-01-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06387173
The ClinicalTrials.gov registry entry for NCT06387173 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 454-participant average among 4 other Early Stage Breast Carcinoma trials with a reported enrollment target (100% lower). The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Early Stage Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06387173 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06387173 about?
NCT06387173 is a clinical study titled "Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer". This study evaluates the side effects and outcomes of patients who undergo cryoablation for early stage breast cancer.
What is the current status of trial NCT06387173?
This trial is currently active not recruiting. The enrollment target is 2 participants. The study started on 2024-01-04. Estimated completion is 2099-01-03.
What conditions does trial NCT06387173 study?
This clinical trial studies the following conditions: Early Stage Breast Carcinoma.
What interventions are being tested in trial NCT06387173?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06387173?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06387173 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Early Stage Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
RECRUITING · Phase 3
-
Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors
RECRUITING · Phase 2
-
Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer
RECRUITING
-
Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.